Investment firm Opaleye Management Inc. has increased its stake in Harrow Inc. (NASDAQ:HROW), a pharmaceutical company, with a recent purchase of shares valued at $199,400. The transaction involved the acquisition of 20,000 shares at a weighted average price of $9.97 per share, according to a regulatory filing.
The shares were bought in multiple transactions with prices ranging from $9.91 to $10.01. This purchase brings Opaleye Management's total ownership in Harrow Inc. to 3,815,000 shares. The investment manager may be deemed to beneficially own these securities, which are directly owned by Opaleye, L.P.
Investors often monitor such filings to gauge the confidence that significant shareholders, such as investment firms and insiders, have in the company's prospects. The actions of these large stakeholders can provide insights into the company's performance and strategic direction.
Opaleye Management Inc. has not disclosed any specific intentions or future plans regarding its investment in Harrow Inc. following this latest transaction. The firm, based in Boston, MA, is known for its investments in the healthcare sector, particularly in pharmaceutical companies like Harrow Inc.
The financial details of the transaction were confirmed by James Silverman, President of Opaleye Management Inc., in a signature dated April 25, 2024. The filing did not mention any sales of Harrow Inc. stock by the investment firm.
InvestingPro Insights
Opaleye Management Inc.'s recent increase in stake in Harrow Inc. (NASDAQ:HROW) signals a strategic move that aligns with the current financial metrics and market performance of the pharmaceutical company. Harrow Inc.'s market capitalization stands at $353.63 million, reflecting a notable presence in the sector. Despite a challenging profitability outlook, with analysts not expecting the company to be profitable this year, Harrow Inc. has demonstrated strong revenue growth over the last twelve months, boasting an increase of 46.95%. This growth trajectory is further highlighted by a substantial quarterly revenue jump of 78.83% in Q1 2023.
InvestingPro Tips reveal that Harrow Inc.'s liquid assets surpass its short-term obligations, indicating a level of financial stability that may reassure investors like Opaleye Management. However, the company's trading at a high EBITDA valuation multiple suggests that the market has high expectations for its future earnings before interest, taxes, depreciation, and amortization. This is an important consideration for investors evaluating the company's stock value in relation to its earnings potential.
For those interested in a deeper analysis, there are additional InvestingPro Tips available, which provide insights into Harrow Inc.'s financial health and market position. To explore these further, one can visit https://www.investing.com/pro/HROW and use the coupon code PRONEWS24 to get an additional 10% off a yearly or biyearly Pro and Pro+ subscription. The InvestingPro platform lists a total of 7 tips for Harrow Inc., offering a comprehensive view for informed investment decisions.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.